Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Polycystic Ovary Syndrome
100%
Surfactant Protein A (SP-A)
51%
During Pregnancy
29%
Pregnant Women
26%
95% Confidence Interval
22%
Human Papillomavirus
22%
Women of Reproductive Age
20%
Women's Health
20%
Pennsylvania
17%
HPV16
16%
Obesity
16%
Infertility
15%
Randomized Controlled Trial
15%
Cervical Cancer
14%
Live Birth
14%
Body Mass Index
14%
Tumor
14%
Obstetrics and Gynaecology
13%
Gynecologic Oncology Group
13%
Spa2
12%
Risk Factors
12%
Caspase-1
12%
Hysterectomy
12%
Physical Activity
12%
United States
12%
Odds Ratio
11%
Ovarian Cancer
11%
Gestational Weight Gain
11%
Group Studies
11%
Estrogen
11%
Surfactant Protein B
10%
Fetus
10%
Preeclampsia
10%
Ovulation
10%
Human Papillomavirus Types
10%
Endometrial Cancer
10%
Adjusted Odds Ratio
10%
Gestational Age
9%
Insulin Resistance
9%
COVID-19
9%
Clinical Trials
9%
Ovulation Induction
9%
Pregnancy Outcome
9%
Cesarean Delivery
9%
Theca Cells
9%
Health Studies
9%
Testosterone
9%
Lung
8%
Metformin
8%
Single nucleotide Polymorphism
8%
Young Women
8%
In Vitro Fertilization
8%
Unexplained Infertility
8%
Pulmonary Surfactant
8%
General Anesthesia
7%
Catechol Estrogens
7%
Endometriosis
7%
High Risk
7%
Chemotherapy
7%
Infertility Treatment
7%
Alveolar Macrophages
7%
Exercise Behavior
7%
Clomiphene Citrate
7%
Meta-analysis
7%
Estradiol
6%
Keratinocytes
6%
Androgens
6%
Oral Contraceptives
6%
Randomized Trial
6%
Non-associated
6%
Placebo
6%
Bone Mineral Density
6%
Postmenopausal Women
6%
Reproductive Medicine
6%
Ovarian Stimulation
6%
Birth Weight
6%
HPV18
5%
Counseling
5%
Surfactant Protein D (SP-D)
5%
Gonadotropins
5%
Respiratory Distress Syndrome
5%
Protein-coding Genes
5%
Radiation Therapy
5%
Older Women
5%
Overall Survival
5%
Clomiphene
5%
Energy Intake
5%
High-risk Human Papillomavirus (HR-HPV)
5%
Rat Lung
5%
Metabolic Syndrome
5%
Ultrasound
5%
Retrospective Cohort Study
5%
Assisted Reproductive Technology
5%
Cervical Carcinoma
5%
Overweight/obesity
5%
Obese Women
5%
Gene Expression
5%
Sex Differences
5%
Contraceptive Use
5%
Penn State
5%
Medicine and Dentistry
Polycystic Ovary Syndrome
64%
Diseases
28%
Cesarean Section
18%
Gynecological Oncology
17%
Hysterectomy
15%
Odds Ratio
15%
Randomized Controlled Trial
14%
fertility
13%
Prevalence
13%
Cervical Cancer
13%
Body Mass Index
13%
Obstetrics
12%
Neoplasm
12%
Clinical Trial
12%
Surfactant Protein A
11%
Uterine Cancer
11%
Infection
10%
Reproductive Medicine
10%
Womens Health
10%
Chemotherapy
9%
Reproductive Age
9%
Ovarian Cancer
9%
Lung
9%
Cancer
9%
Premature Labor
9%
Ovulation
9%
Surfactant Protein
8%
Gestational Age
8%
In Vitro Fertilisation
8%
Adolescence
8%
Androgen
8%
Recurrent Disease
8%
Education
8%
Radiation Therapy
8%
Pre-Eclampsia
8%
Unexplained Infertility
8%
Glycon
8%
Embryo Transfer
8%
COVID-19
8%
Health Care Cost
8%
Pregnant Woman
8%
Assisted Reproductive Technology
8%
Malignant Neoplasm
7%
Hypertension
7%
General Anesthesia
7%
Endometriosis
7%
Neonatal Infant
7%
Glucose
7%
First Trimester Pregnancy
7%
Gynecology
7%
Pelvis
7%
Wart Virus
7%
Ovulation Induction
7%
Conception
7%
Logistic Regression Analysis
7%
Papanicolaou Stain
6%
Krukenberg Tumor
6%
Insulin Resistance
6%
Birth Rate
6%
Primary Health Care
6%
Morbidity
6%
Genetics
6%
Hyperandrogenism
6%
Counseling
6%
Surgery
6%
Tumor
6%
Clomifene Citrate
6%
Insulin
6%
Placebo
6%
Prematurity
6%
Endometrium Carcinoma
5%
Health Care
5%
Diabetes
5%
Laparoscopic Surgery
5%
Vaginal Delivery
5%
Arm
5%
Cervix
5%
Birth Weight
5%
Quality of Life
5%
Clomifene
5%
Child Health
5%
Physical Activity
5%
Obesity
5%
Blood Pressure
5%
Meta-Analysis
5%
Clinician
5%
Contraception
5%